MKI67 and breast carcinoma: In line with this, in silico sampling of TMA equivalent cores from whole slide images for Ki67 estimation in breast cancer has showed that optimal tissue sampling for IHC biomarker evaluation is dependent on the heterogeneity of the studied tissue, which may require a substantial number of TMA cores to be sampled to achieve a low error in heterogenous tumours33.